Leave a Reply

Your email address will not be published.

Next Post

Merck Raises Full-Year Profit Target After Cancer Drug Sales Help Third-Quarter Beat-US News | The Epoch Times

Thu Oct 28 , 2021
Merck & Co. Inc. raised its full-year adjusted profit forecast on Thursday, after strong demand for its blockbuster cancer drug Keytruda and recovery in sales of its non-COVID-19 vaccines helped it beat third-quarter profit estimates. Sales of vaccines and physician-administered drugs have started to improve as hospitals and clinics adapt […]

Chief Editor

Johny Watshon

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur

Quick Links

Newsletter Signup

Sign up now and never miss a thing!

You're Signed Up!

Now that you are signed up, we will send you exclusive offers periodically.